Ex, I have no idea what you are talking about. Unless I missed something, this is a blinded trial with an SOC control arm. This is not a single arm trial. The Phase III trial lives or dies on separation from the control arm for PFS and/or OS. Three of three leading DCVax-L researchers agree, efficacy impact will be evaluated by comparing the arms.